Skip to main content
Top
Published in: BMC Psychiatry 1/2007

Open Access 01-12-2007 | Research article

Early onset of treatment effects with oral risperidone

Authors: Thomas J Raedler, Andreas Schreiner, Dieter Naber, Klaus Wiedemann

Published in: BMC Psychiatry | Issue 1/2007

Login to get access

Abstract

Background

The dogma of a delayed onset of antipsychotic treatment effects has been maintained over the past decades. However, recent studies have challenged this concept. We therefore performed an analysis of the onset of antipsychotic treatment effects in a sample of acutely decompensated patients with schizophrenia.

Methods

In this observational study, 48 inpatients with acutely decompensated schizophrenia were offered antipsychotic treatment with oral risperidone. PANSS-ratings were obtained on day 0, day 1, day 3, day 7 and day 14.

Results

Significant effects of treatment were already present on day 1 and continued throughout the study. The PANSS positive subscore and the PANSS total score improved significantly more than the PANSS negative subscore.

Conclusion

Our results are consistent with the growing number of studies suggesting an early onset of antipsychotic treatment effects. However, non-pharmacological effects of treatment also need to be taken into consideration.
Literature
1.
go back to reference Agid O, Kapur S, Arenovich T, Zipursky RB: Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry. 2003, 60: 1228-1235. 10.1001/archpsyc.60.12.1228.CrossRefPubMed Agid O, Kapur S, Arenovich T, Zipursky RB: Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry. 2003, 60: 1228-1235. 10.1001/archpsyc.60.12.1228.CrossRefPubMed
2.
go back to reference Leucht S, Busch R, Hamann J, Kissling W, Kane JM: Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended. Biol Psychiatry. 2005, 57: 1543-1549. 10.1016/j.biopsych.2005.02.023.CrossRefPubMed Leucht S, Busch R, Hamann J, Kissling W, Kane JM: Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended. Biol Psychiatry. 2005, 57: 1543-1549. 10.1016/j.biopsych.2005.02.023.CrossRefPubMed
3.
go back to reference Raedler TJ, Schreiner A, Naber D, Wiedemann K: Risperidone in the treatment of acute schizophrenia. J Clin Psychopharmacol. 2004, 24: 335-338. 10.1097/01.jcp.0000126660.50788.ef.CrossRefPubMed Raedler TJ, Schreiner A, Naber D, Wiedemann K: Risperidone in the treatment of acute schizophrenia. J Clin Psychopharmacol. 2004, 24: 335-338. 10.1097/01.jcp.0000126660.50788.ef.CrossRefPubMed
4.
go back to reference Rojo JE, Gibert K, Cobo J, Rodriguez-Cano E, Vallejo J: Onset of antidepressant action: a pharmacological question?. Hum Psychopharmacol. 2005, 20: 425-433. 10.1002/hup.708.CrossRefPubMed Rojo JE, Gibert K, Cobo J, Rodriguez-Cano E, Vallejo J: Onset of antidepressant action: a pharmacological question?. Hum Psychopharmacol. 2005, 20: 425-433. 10.1002/hup.708.CrossRefPubMed
5.
go back to reference Mitchell AJ: Two-week delay in onset of action of antidepressants: new evidence. Br J Psychiatry. 2006, 188: 105-106. 10.1192/bjp.bp.105.011692.CrossRefPubMed Mitchell AJ: Two-week delay in onset of action of antidepressants: new evidence. Br J Psychiatry. 2006, 188: 105-106. 10.1192/bjp.bp.105.011692.CrossRefPubMed
6.
go back to reference Kapur S, Arenovich T, Agid O, Zipursky R, Lindborg S, Jones B: Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry. 2005, 162: 939-946. 10.1176/appi.ajp.162.5.939.CrossRefPubMed Kapur S, Arenovich T, Agid O, Zipursky R, Lindborg S, Jones B: Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry. 2005, 162: 939-946. 10.1176/appi.ajp.162.5.939.CrossRefPubMed
7.
go back to reference Small JG, Kolar MC, Kellams JJ: Quetiapine in schizophrenia: onset of action within the first week of treatment. Curr Med Res Opin. 2004, 20: 1017-1023. 10.1185/030079904125004033.CrossRefPubMed Small JG, Kolar MC, Kellams JJ: Quetiapine in schizophrenia: onset of action within the first week of treatment. Curr Med Res Opin. 2004, 20: 1017-1023. 10.1185/030079904125004033.CrossRefPubMed
8.
go back to reference Möller HJ, Bäuml J, Ferrero F, Fuger J, Geretsegger C, Kasper S, Kissling W, Schubert H: Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland. Eur Arch Psychiatry Clin Neurosci. 1997, 247: 291-296.CrossRefPubMed Möller HJ, Bäuml J, Ferrero F, Fuger J, Geretsegger C, Kasper S, Kissling W, Schubert H: Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland. Eur Arch Psychiatry Clin Neurosci. 1997, 247: 291-296.CrossRefPubMed
9.
go back to reference Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P: Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group. Am J Psychiatry. 1998, 155: 499-504.CrossRefPubMed Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P: Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group. Am J Psychiatry. 1998, 155: 499-504.CrossRefPubMed
10.
go back to reference Huttunen MO, Piepponen T, Rantanen H, Larmo I, Nyholm R, Raitasuo V: Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial. Acta Psychiatr Scand. 1995, 91: 271-277.CrossRefPubMed Huttunen MO, Piepponen T, Rantanen H, Larmo I, Nyholm R, Raitasuo V: Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial. Acta Psychiatr Scand. 1995, 91: 271-277.CrossRefPubMed
Metadata
Title
Early onset of treatment effects with oral risperidone
Authors
Thomas J Raedler
Andreas Schreiner
Dieter Naber
Klaus Wiedemann
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2007
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-7-4

Other articles of this Issue 1/2007

BMC Psychiatry 1/2007 Go to the issue